Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
In addition to AVT06, which is a biosimilar candidate for Eylea ® (aflibercept) 2 mg, Alvotech is currently also developing AVT29, a biosimilar candidate for Eylea ® HD (aflibercept) 8 mg. Teva also ...
pna1d
DA: Green light for commercial vaccination vs. ASF eyed in April
The commercial vaccination against African swine fever (ASF) may secure a go signal in April, the Department of Agriculture ...
Global Market for Rare Disease Diagnostics to Grow at 9.9% CAGR
According to the latest study from BCC Research, "Rare Disease Diagnostics: Technologies and Global Markets" is projected to ...
What’s the Difference Between the FDA and the USDA?
Explaining America’s weirdly complicated food inspection system, including who regulates poultry and eggs and how Robert F.
manilastandard5d
US FDA marketing authorizations for Zyn encourage Filipino harm reduction advocates
Tobacco harm reduction advocates in the Philippines lauded the U.S. Food and Drug Administration’s marketing authorizations ...
Rappler17d
DA seeks chicken imports, vaccine approval to avert possible egg shortage in April
Philippines – The Department of Agriculture is scrambling to import egg-laying chickens and pressing the Food and Drug Administration to fast-track the approval of avian flu vaccines to avoid an ...
Yahoo Finance21d
Ozempic's FDA Approval Just Sent Shockwaves Through the Kidney Disease Market
Novo Nordisk (NYSE:NVO) just scored a game-changing FDA approval for Ozempic, expanding its use beyond diabetes to tackle chronic kidney disease and cardiovascular risks. The move solidifies ...
Wall Street Journal21d
Novo Nordisk’s Ozempic Gets FDA Approval as Kidney-Disease Treatment
Novo Nordisk said the Food and Drug Administration approved the diabetes-drug Ozempic to be used to help kidney-disease patients. Ozempic, or semaglutide, can now be used to reduce the risk of ...
CNN21d
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
The new indications, approved Tuesday by the FDA, make Ozempic the most broadly indicated drug in its class, with the largest set of specific medical conditions that it may be prescribed to treat.
ABC News22d
Once again, Trump starts a term with a weak approval rating
Today, 538 is unveiling a new polling average for President Donald Trump's job approval rating. Based on the 11 polls released since his inauguration on Jan. 20, Trump's average approval rating ...
Cure Today22d
FDA Approves Enhertu for HER2-Low and -Ultralow Breast Cancer
The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer with disease progression after endocrine therapy. The Food and Drug ...
Reuters22d
US FDA approves Novo Nordisk's Ozempic to cut risk of diabetic kidney disease progression
Jan 28 (Reuters) - The U.S. FDA has approved Novo Nordisk's (NOVOb.CO), opens new tab Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart ...